Search
Patexia Research
Case number 2016-1008

Millennium Pharmaceuticals v. Mylan Laboratories Limited > Documents

Date Field Doc. No.Description (Pages)
Oct 27, 2017 21 Mandate issued to the United States District Court for the District of Delaware. Service as of this date by Clerk of Court. [471000] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [SJ] [Entered: 10/27/2017 09:40 AM] (2)
Jul 17, 2017 20 OPINION and JUDGMENT filed. The judgment or decision is: Reversed-in-part and Remanded-in-part in 15-2066, 16-1008, 16-1009, 16-1010, 16-1110, 16-1283, 16-1762; Vacated-in-part and Remanded-in-part in 16-1109. (Precedential Opinion). (For the Court: Newman,Circuit Judge; Mayer,Circuit Judge and O'Malley,Circuit Judge). [446874] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110, 16-1283, 16-1762] [JAB] [Entered: 07/17/2017 10:14 AM] (25)
Nov 2, 2015 19 CORRECTED ORDER: correcting clerk order to consolidate appeals [17], clerk order [17]; reason(s): to correct appellant's opening brief deadline. Service as of this date by Clerk of Court. [285098] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 11/02/2015 09:52 AM] (2)
Oct 30, 2015 17 ORDER consolidating appeals (15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110). Service as of this date by Clerk of Court. [284905] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 02:55 PM] (0)
Oct 30, 2015 18 Note to file: The following cases are associated:15-2066 (Lead) with 16-1008, -1009, -1010, -1109, and -1110 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [284931] [15-2066, 16-1008, 16-1009, 16-1010, 16-1109, 16-1110] [CAB] [Entered: 10/30/2015 03:33 PM] (0)
Oct 22, 2015 16 Entry of appearance for Emily R. Whelan as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/22/2015 by email. [282721] [Emily Whelan] [Entered: 10/22/2015 12:01 PM] (2)
Oct 19, 2015 3 Entry of appearance for Tung-On Kong as principal counsel for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 10/19/2015 by email. [281515] [Tung Kong] [Entered: 10/19/2015 04:16 PM] (2)
Oct 19, 2015 4 Certificate of Interest for the Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 10/19/2015 by email. [281517] [Tung Kong] [Entered: 10/19/2015 04:17 PM] (2)
Oct 19, 2015 5 Entry of appearance for Elham F. Steiner as of counsel for Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 10/19/2015 by email. [281521] [Elham Steiner] [Entered: 10/19/2015 04:20 PM] (2)
Oct 19, 2015 6 Docketing Statement for the Appellees Agila Specialties Inc. and Mylan Laboratories Limited. Service: 10/19/2015 by email. [281522] [Elham Steiner] [Entered: 10/19/2015 04:21 PM] (4)
Oct 19, 2015 7 Entry of appearance for William F. Lee as principal counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281554] [William Lee] [Entered: 10/19/2015 05:21 PM] (2)
Oct 19, 2015 8 Entry of appearance for Lisa J. Pirozzolo as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281558] [Lisa Pirozzolo] [Entered: 10/19/2015 05:28 PM] (2)
Oct 19, 2015 9 Entry of appearance for Robert M. Galvin as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281563] [Robert Galvin] [Entered: 10/19/2015 05:33 PM] (2)
Oct 19, 2015 10 Entry of appearance for Mark C. Fleming as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281571] [Mark Fleming] [Entered: 10/19/2015 05:38 PM] (2)
Oct 19, 2015 11 Entry of appearance for Jason H. Liss as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281577] [Jason Liss] [Entered: 10/19/2015 05:44 PM] (2)
Oct 19, 2015 12 Entry of appearance for Anna E. Lumelsky as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281581] [Anna Lumelsky] [Entered: 10/19/2015 05:49 PM] (2)
Oct 19, 2015 13 Entry of appearance for Tasha J. Bahal as of counsel for Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281585] [Tasha Bahal] [Entered: 10/19/2015 05:54 PM] (2)
Oct 19, 2015 14 Certificate of Interest for the Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281591] [William Lee] [Entered: 10/19/2015 06:00 PM] (2)
Oct 19, 2015 15 Docketing Statement for the Appellant Millennium Pharmaceuticals, Inc.. Service: 10/19/2015 by email. [281593] [William Lee] [Entered: 10/19/2015 06:01 PM] (4)
Oct 16, 2015 2 Note to file: 16-1008, 16-1009, 16-1010 (COMPANION started 10/16/2015) with 15-2066. These cases shall be considered companion cases and assigned to the same merits panel for oral argument. [281115] [15-2066, 16-1008, 16-1009, 16-1010] [CAB] [Entered: 10/16/2015 04:19 PM] (0)
Oct 5, 2015 1 Appeal docketed. Received: 10/01/2015. [277494]Entry of Appearance due 10/19/2015. Certificate of Interest is due on 10/19/2015. Docketing Statement due 10/19/2015. Appellant's brief is due 12/04/2015. [AT] [Entered: 10/05/2015 10:26 AM] (13)
Menu